Divis Laboratories soras on reporting 64% jump in Q2 consolidated net profit
Divi's Laboratories is currently trading at Rs. 11561.20, up by 480.95 points or 4.34% from its previous closing of Rs. 11080.25 on the BSE.
The scrip opened at Rs. 11105.00 and has touched a high and low of Rs. 11,591.30 and Rs. 11,066.15 respectively. So far 761 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 11,656.15 on 09-Nov-2026 and a 52 week low of Rs. 5648.00 on 02-Apr-2026.
Last one week high and low of the scrip stood at Rs. 11,656.15 and Rs. 9866.35 respectively. The current market cap of the company is Rs. 294145.82 crore.
The promoters holding in the company stood at 51.88%, while Institutions and Non-Institutions held 39.55% and 8.58% respectively.
Divis Laboratories has reported 63.79% jump in its net profit at Rs 1,140 crore for the quarter ended September 30, 2026 (Q2FY27) as compared to Rs 696 crore for the same quarter in the previous year. The total income of the company has increased by 33.11% at Rs 3,735 crore for Q2FY27 as compared to Rs 2,806 crore for the corresponding quarter of the previous year.
On consolidated basis, the company has reported 63.57% jump in its net profit at Rs 1,127 crore for the quarter ended September 30, 2026 as compared to Rs 689 crore for the same quarter in the previous year. The total income of the company increased by 31.82% at Rs 3,770 crore for Q2FY27 as compared to Rs 2,860 crore for the corresponding quarter previous year.
